Gene · 55165
Papers1,450
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,450
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Statement of Retraction: Circular RNA_0120376 regulates microRNA-148b-3 and centrosomal protein 55 to promote non-small cell lung cancer development. | Bioengineered | 2026 | 42821368 | PubTator, text mining | PubMed |
| Strategies for Cervical Cancer Treatment using the Regenerative Potentials of Mesenchymal Stem Cells. | Curr Pharm Des | 2026 | 42817134 | PubTator, text mining | PubMed |
| Clinical translation of senescence-related pan-cancer multi-omics: tools for assessment and immunotherapy prediction. | Cancer Gene Ther | 2026 | 42722723 | PubTator, text mining | PubMed |
| Integrative multi-omics identifies a four-gene diagnostic signature linking immune dysfunction and airway remodeling in COPD. | Ther Adv Respir Dis | 2026 | 42631563 | PubTator, text mining | PubMed |
Retraction notice to "UBTD2 protein molecules emerges as a key prognostic protein marker in glioma: Insights from integrated omics and machine learning analysis of GRM7, NCAPG, CEP55, and other biomarkers" [Int. J. Biol. Macromol. 310 (2025) 143473]. | Int J Biol Macromol | 2026 | 42527167 | PubTator, text mining | PubMed |
| Mitotic Hub Gene Network in Colorectal Cancer: Integrated Transcriptomic, Protein-Level, and Clinical-Genomic Characterization of a Ten-Gene Signature. | Genes (Basel) | 2026 | 42510823 | PubTator, text mining | PubMed |
| A Novel Technology Platform for Extracellular Vesicle-Targeted Expression of Drug-Metabolizing Enzymes: Driving CYP3A4 Expression and Secretion via the EABR Motif. | Biomedicines | 2026 | 42351727 | PubTator, text mining | PubMed |
| Proteomics in myelodysplastic syndromes: towards novel prognostic and diagnostic biomarkers. | Biochem Med (Zagreb) | 2026 | 42299353 | PubTator, text mining | PubMed |
| WTAP-mediated m6A methylation of CEP55 promotes immune evasion in lung adenocarcinoma by activating the PI3K/AKT/mTOR pathway. | Mol Genet Genomics | 2026 | 42298019 | PubTator, text mining | PubMed |
| Pyroptosis-Related Gene Signatures and Immune Modulation in Ovarian Cancer: Insights from Multi-Omics and Machine Learning. | Genes (Basel) | 2026 | 42195052 | PubTator, text mining | PubMed |
| Integrating bulk RNA-seq and ScRNA-seq to identify manganese metabolism-related subtypes and immunoregulatory mechanisms in liver hepatocellular carcinoma. | Open Life Sci | 2026 | 42064840 | PubTator, text mining | PubMed |
| Prognostic significance of CEP55 expression in non-small cell lung cancer: a systematic review and meta-analysis. | BMC Pulm Med | 2026 | 42001102 | PubTator, text mining | PubMed |
| Machine learning-based multi-omic analysis identifies CEP55, DLGAP5, and EZH2 as regulated cell death biomarkers linked to immunotherapy resistance in hepatocellular carcinoma. | Naunyn Schmiedebergs Arch Pharmacol | 2026 | 41984188 | PubTator, text mining | PubMed |
| Effects of CRISPR-Cas9-mediated CEP55 gene knockout on immune evasion mechanisms of liver cancer cells. | Sci Rep | 2026 | 41951696 | PubTator, text mining | PubMed |
| Humanized extracellular vesicles for efficient RNA delivery. | Proc Natl Acad Sci U S A | 2026 | 41945434 | PubTator, text mining | PubMed |
| Molecular and Functional Platelet Abnormalities in Myeloproliferative Neoplasms. | Cells | 2026 | 41892345 | PubTator, text mining | PubMed |
| A cell cycle-dependent transition of acetylation to phosphorylation regulates timely centrosome maturation. | Nat Commun | 2026 | 41862458 | PubTator, text mining | PubMed |
| Genetic landscape and phenotypic correlations of lissencephaly: prenatal and postnatal insights. | Brain Commun | 2026 | 41853045 | PubTator, text mining | PubMed |
| Identification of potential key genes and molecular mechanisms of oral squamous cell carcinoma based on integrated bioinformatics approach. | J Genet Eng Biotechnol | 2026 | 41839689 | PubTator, text mining | PubMed |
| BRAF inhibitor resistance in melanoma: from resistance mechanisms to therapeutic innovations. | Mol Biomed | 2026 | 41807883 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/55165/papers